Unknown

Dataset Information

0

Development and validation of chemical features-based proton-coupled folate transporter/activity and reduced folate carrier/activity models (pharmacophores).

ABSTRACT: All clinically used antifolates lack transport selectivity for tumors over normal cells resulting in dose-limiting toxicities. There is growing interest in developing novel tumor-targeted cytotoxic antifolates with selective transport into tumors over normal cells via the proton-coupled folate transporter (PCFT) over the ubiquitously expressed reduced folate carrier (RFC). A lack of X-ray crystal structures or predictive models for PCFT or RFC has hindered structure-aided drug design for PCFT-selective therapeutics. Four-point validated models (pharmacophores) were generated for PCFT/Activity (HBA, NI, RA, RA) and RFC/Activity (HBD, NI, HBA, HBA) based on inhibition (IC50) of proliferation of isogenic Chinese hamster ovary (CHO) cells engineered to express only human PCFT or only RFC. Our results revealed substantial differences in structural features required for transport of novel molecules by these transporters which can be utilized for developing transporter-selective antifolates.

SUBMITTER: Shah K 

PROVIDER: S-EPMC5959037 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Development and validation of chemical features-based proton-coupled folate transporter/activity and reduced folate carrier/activity models (pharmacophores).

Shah Khushbu K   Raghavan Sudhir S   Hou Zhanjun Z   Matherly Larry H LH   Gangjee Aleem A  

Journal of molecular graphics & modelling 20180220

All clinically used antifolates lack transport selectivity for tumors over normal cells resulting in dose-limiting toxicities. There is growing interest in developing novel tumor-targeted cytotoxic antifolates with selective transport into tumors over normal cells via the proton-coupled folate transporter (PCFT) over the ubiquitously expressed reduced folate carrier (RFC). A lack of X-ray crystal structures or predictive models for PCFT or RFC has hindered structure-aided drug design for PCFT-se  ...[more]

Similar Datasets

Unknown The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier.
| S-EPMC2716086 | biostudies-literature
Unknown Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
| S-EPMC7226238 | biostudies-literature
Unknown Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits ?-glycinamide ribonucleotide formyltransferase.
| S-EPMC3209708 | biostudies-literature
Unknown Experimentally optimized threading structures of the proton-coupled folate transporter.
| S-EPMC4794783 | biostudies-literature
Unknown Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry.
| S-EPMC2730022 | biostudies-literature
Unknown Synthesis and biological activity of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as inhibitors of de novo purine biosynthesis with selectivity for cellular uptake by high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier.
| S-EPMC3288238 | biostudies-literature
Unknown Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry.
| S-EPMC2836843 | biostudies-literature
Unknown Delineating the extracellular water-accessible surface of the proton-coupled folate transporter.
| S-EPMC3799626 | biostudies-literature
Unknown Mutation of the proton-coupled folate transporter gene (PCFT-SLC46A1) in Turkish siblings with hereditary folate malabsorption.
| S-EPMC3885236 | biostudies-literature
Unknown Role of the glutamate 185 residue in proton translocation mediated by the proton-coupled folate transporter SLC46A1.
| S-EPMC2711648 | biostudies-literature